A Study To Assess The Safety And Efficacy Of SU11248 In Patients With Gastrointestinal Stromal Tumor(GIST)
Completed · Phase 3 · Has a placebo group
Conditions studied: Gastrointestinal Stromal Tumor
In brief
A study to assess the safety and efficacy of SU11248 in patients with gastrointestinal stromal tumor (GIST) whose disease has failed imatinib therapy or who were intolerant to imatinib treatment.
Key facts
- Study ID
- NCT00075218
- Run by
- Pfizer
- People needed
- 361
- Starts
- 2003-12-01
- Expected to finish
- 2008-05-01
- Last updated by the study team
- 2009-09-28
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Pfizer Investigational Site — Los Angeles, California, United States
- Pfizer Investigational Site — Los Angeles, California, United States
- Pfizer Investigational Site — Pasadena, California, United States
- Pfizer Investigational Site — Santa Monica, California, United States
- Pfizer Investigational Site — Stanford, California, United States
- Pfizer Investigational Site — Washington D.C., District of Columbia, United States
- Pfizer Investigational Site — Miami, Florida, United States
- Pfizer Investigational Site — Tampa, Florida, United States
- Pfizer Investigational Site — Park Ridge, Illinois, United States
- Pfizer Investigational Site — Boston, Massachusetts, United States
- Pfizer Investigational Site — Detroit, Michigan, United States
- Pfizer Investigational Site — Minneapolis, Minnesota, United States
- Pfizer Investigational Site — St Louis, Missouri, United States
- Pfizer Investigational Site — New York, New York, United States
- Pfizer Investigational Site — New York, New York, United States
- Pfizer Investigational Site — New York, New York, United States
- Pfizer Investigational Site — Durham, North Carolina, United States
- Pfizer Investigational Site — Cleveland, Ohio, United States
- Pfizer Investigational Site — Columbus, Ohio, United States
- Pfizer Investigational Site — Columubs, Ohio, United States
- Pfizer Investigational Site — Portland, Oregon, United States
- Pfizer Investigational Site — Philadelphia, Pennsylvania, United States
- Pfizer Investigational Site — Nashville, Tennessee, United States
- Pfizer Investigational Site — Seattle, Washington, United States
- Pfizer Investigational Site — Duarte, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.